entertainment -WSS

entertainment

author：focus 2025-09-28 23:49:05 - browse：28642

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： TB outbreak tied to bone grafts underscores testing shortcomings

hotspot

WSS

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Listen: Your guide to Wegovy's blockbuster heart study

Large hospital system sues Multiplan for low

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Genentech weighs delaying cancer therapy after drug pricing law

Why does health care cost so much? A reading guide

knowledge

entertainment

explore

In Memoriam: Notable people who died in 2023

Covid's long

Hollywood unions extend contract negotiations for actors

Why does health care cost so much? A reading guide

Peter Hotez and the public health issue of online harassment

Health care needs a new profession: neuroimaging counseling

Sports medicine is finally prioritizing gender equality

Cholera vaccine supply gets boost as demand surges globally

Walensky prepares to leave CDC — and Congress — behind

Why rehabilitation engineers need to center patients in their research

Wikipedia

Covid's long

Getting Alzheimer's drug Leqembi to patients can be a challenge

MassMutual is introducing free genetic testing for members

Q&A: Jennifer Adair on making gene therapy available globally

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Genentech weighs delaying cancer therapy after drug pricing law

hotspot

leisure time

hotspot

leisure time